Medicines Australia says it welcomes the Department of Health, Disability and Ageing's "clear and positive recommendations to Government, to focus on implementation and delivery of the next critical phase for the HTA Review, within the recently released Incoming Government Brief."
Medicines Australia backs focus on listings and productivity in government brief
July 3, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
CSL unveils US expansion, cementing its position as a global biopharma leader
November 19, 2025 - - Latest News -
Cleo Diagnostics appoints U.S. oncologist as first key opinion leader
November 19, 2025 - - Australian Biotech -
IDT Australia resets strategy as advanced therapies drive new phase of growth
November 19, 2025 - - BioPharma -
Dimerix Phase 3 kidney trial clears seventh safety review
November 19, 2025 - - Australian Biotech -
Prescient secures EU orphan status for PTX-100 for cutaneous T-cell lymphomas
November 19, 2025 - - Australian Biotech -
BCAL advances early cancer detection portfolio as Australian launch looms
November 19, 2025 - - Australian Biotech -
Is this disconnect so entrenched we can no longer recognise the presence of a problem?
November 19, 2025 - - Latest News